Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology EMR Software Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Ophthalmology EMR Software...
-
Cheapest Compounded Semaglutide without insurance 2026: What low-cost GLP-1 pricing often excludes from total monthly cost—consumer framework.
-
60 Degrees Pharma partners with Runway Health to give international travelers direct telehealth access to once-weekly ARAKODA for malaria prevention.
-
Wegovy Pill by Ro: January 2026 consumer analysis examines oral GLP-1 legitimacy, Novo Nordisk integration, and no-insurance cash-pay options.
-
New capabilities enable Teladoc Health’s care teams to address a broader spectrum of health needs, delivering more value in virtual urgent care visits
-
Direct Meds reviews best GLP-1 weight loss shot prescription pathways for 2026 as oral semaglutide and injectable formats expand patient access.
-
Ipamorelin vs Sermorelin 2026 analysis compares growth hormone peptide mechanisms, regulatory status, and prescription telehealth access pathways.
-
MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs
Analysis examines MEDVi's compounded GLP-1 semaglutide telehealth model, FDA compounding framework, and prescription weight loss trends for 2026.
-
NAD+ research examines cellular aging as telehealth expands peptide therapy access — RenuviaRX platform model, pricing, and oversight revealed.
-
Best peptides for skin care: Consumer analysis examines injectable Glutathione tripeptide vs topical delivery for January 2026 wellness planning.